Abstract | OBJECTIVE: METHODS: RESULTS: AHH activity in peripheral lymphocytes was (4.9 +/- 2.1) pmol.min-1 x 10(-6) cells in patients with lung cancer, (7.3 +/- 1.9) pmol.min-1 x 10(-6) cells in patients with lung squamous carcinoma, (1.1 +/- 0.7) and (1.2 +/- 0.6) pmol.min-1 x 10(-6) cells in healthy subjects and patients with benign lung diseases respectively. It is indicated that AHH activity in peripheral lymphocytes was significantly increased in patients with lung cancer, especially with lung squamous cancer. Of patients with lung cancer, AHH activity was (3.7 +/- 1.4) pmol.min-1 x 10(-6) cells in patient at stage I, II, (5.1 +/- 2.1), (7.1 +/- 1.8) pmol.min-1 x 10(-6) cells at stage III and stage IV, and AHH activity increased when patients deteriorated, vice versa. Diagnosis evaluation test indicated that AHH was over 80% in both sensitivity and specificity. AHH relative risk to lung cancer was 2.83. CONCLUSIONS:
|
Authors | L Chen, Y Liu |
Journal | Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
(Zhonghua Jie He He Hu Xi Za Zhi)
Vol. 23
Issue 3
Pg. 151-4
(Mar 2000)
ISSN: 1001-0939 [Print] China |
PMID | 11778487
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Aryl Hydrocarbon Hydroxylases
|
Topics |
- Adult
- Aryl Hydrocarbon Hydroxylases
(blood)
- Biomarkers, Tumor
(blood)
- Female
- Humans
- Lung Neoplasms
(diagnosis, enzymology, pathology)
- Male
- Middle Aged
- Neoplasm Staging
|